{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T04:05:31Z","timestamp":1784433931871,"version":"3.55.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T00:00:00Z","timestamp":1730332800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T00:00:00Z","timestamp":1730332800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1SD2322N"],"award-info":[{"award-number":["1SD2322N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["11K6824N"],"award-info":[{"award-number":["11K6824N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s00204-024-03900-5","type":"journal-article","created":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T10:02:25Z","timestamp":1730368945000},"page":"259-270","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Development and validation of an UPLC-ESI\u2013MS\/MS method for simultaneous quantification of antineoplastic agents and their metabolites in human plasma after unintentional exposure"],"prefix":"10.1007","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2322-0941","authenticated-orcid":false,"given":"Eline","family":"Verscheure","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilana","family":"Struys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Creta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrien","family":"Poels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Vanoirbeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesbeth","family":"Lenaerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Amant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manosij","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lode","family":"Godderis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,31]]},"reference":[{"key":"3900_CR1","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0378-4347(99)00178-4","volume":"729","author":"F Baumann","year":"1999","unstructured":"Baumann F, Lorenz C, Jaehde U, Preiss R (1999) Determination of cyclophosphamide and its metabolites in human plasma by high-performance liquid chromatography-mass spectrometry. J Chromatogr B Biomed Sci Appl 729:297\u2013305. https:\/\/doi.org\/10.1016\/S0378-4347(99)00178-4","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"3900_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2020.121748","volume":"223","author":"H Bavlovi\u010d Pisk\u00e1\u010dkov\u00e1","year":"2021","unstructured":"Bavlovi\u010d Pisk\u00e1\u010dkov\u00e1 H, \u00d8iestad EL, V\u00e1\u0148ov\u00e1 N, Lengvarsk\u00e1 J, \u0160t\u011brbov\u00e1-Kova\u0159\u00edkov\u00e1 P, Pedersen-Bjergaard S (2021) Electromembrane extraction of anthracyclines from plasma: comparison with conventional extraction techniques. Talanta 223:121748. https:\/\/doi.org\/10.1016\/j.talanta.2020.121748","journal-title":"Talanta"},{"issue":"6","key":"3900_CR3","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.3390\/cancers13061238","volume":"13","author":"L Benoit","year":"2021","unstructured":"Benoit L, Mir O, Vialard F, Berveiller P (2021) Cancer during pregnancy: a review of preclinical and clinical transplacental transfer of anticancer agents. Cancers (Basel) 13(6):1238. https:\/\/doi.org\/10.3390\/cancers13061238","journal-title":"Cancers (Basel)"},{"key":"3900_CR4","doi-asserted-by":"publisher","first-page":"124039","DOI":"10.1016\/j.jchromb.2024.124039","volume":"1236","author":"M Briki","year":"2024","unstructured":"Briki M, Murisier A, Guidi M, Seydoux C, Buclin T, Marzolini C, Girardin FR, Thoma Y, Carrara S, Choong E, Decosterd LA (2024) Liquid chromatography coupled to tandem mass spectrometry (LC-MS\/MS) methods for the therapeutic drug monitoring of cytotoxic anticancer drugs: an update. J Chromatogr b: Anal Technol Biomed Life Sci 1236:124039. https:\/\/doi.org\/10.1016\/j.jchromb.2024.124039","journal-title":"J Chromatogr b: Anal Technol Biomed Life Sci"},{"key":"3900_CR5","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1016\/j.ejca.2011.03.008","volume":"47","author":"G Chinnaswamy","year":"2011","unstructured":"Chinnaswamy G, Errington J, Foot A, Boddy AV, Veal GJ, Cole M (2011) Pharmacokinetics of cyclophosphamide and its metabolites in paediatric patients receiving high-dose myeloablative therapy. Eur J Cancer 47:1556\u20131563. https:\/\/doi.org\/10.1016\/j.ejca.2011.03.008","journal-title":"Eur J Cancer"},{"key":"3900_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jpba.2019.04.027","volume":"172","author":"SM Christner","year":"2019","unstructured":"Christner SM, Parise RA, Ivy PS, Tawbi H, Chu E, Beumer JH (2019) Quantitation of paclitaxel, and its 6-alpha-OH and 3-para-OH metabolites in human plasma by LC\u2013MS\/MS. J Pharm Biomed Anal 172:26\u201332. https:\/\/doi.org\/10.1016\/j.jpba.2019.04.027","journal-title":"J Pharm Biomed Anal"},{"key":"3900_CR7","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.jchromb.2007.02.033","volume":"852","author":"R DiFrancesco","year":"2007","unstructured":"DiFrancesco R, Griggs JJ, Donnelly J, DiCenzo R (2007) Simultaneous analysis of cyclophosphamide, doxorubicin and doxorubicinol by liquid chromatography coupled to tandem mass spectrometry. J. Chromatogr B Anal Technol Biomed Life Sci 852:545\u2013553. https:\/\/doi.org\/10.1016\/j.jchromb.2007.02.033","journal-title":"Chromatogr B Anal Technol Biomed Life Sci"},{"key":"3900_CR8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jpba.2013.12.028","volume":"91","author":"MA Fern\u00e1ndez-Peralbo","year":"2014","unstructured":"Fern\u00e1ndez-Peralbo MA, Priego-Capote F, Luque de Castro MD, Casado-Adam A, Arjona-S\u00e1nchez A, Mu\u00f1oz-Casares FC (2014) LC-MS\/MS quantitative analysis of paclitaxel and its major metabolites in serum, plasma and tissue from women with ovarian cancer after intraperitoneal chemotherapy. J Pharm Biomed Anal 91:131\u2013137. https:\/\/doi.org\/10.1016\/j.jpba.2013.12.028","journal-title":"J Pharm Biomed Anal"},{"key":"3900_CR9","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/7967694","author":"S Gao","year":"2018","unstructured":"Gao S, Tao Z, Zhou J, Wang Z, Yun Y, Li M, Zhang F, Chen W, Miao Y (2018) One-step solid extraction for simultaneous determination of eleven commonly used anticancer drugs and one active metabolite in human plasma by HPLC-MS\/MS. J Anal Methods Chem. https:\/\/doi.org\/10.1155\/2018\/7967694","journal-title":"J Anal Methods Chem"},{"key":"3900_CR10","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1002\/rcm.2567","volume":"20","author":"H Gr\u00e9en","year":"2006","unstructured":"Gr\u00e9en H, Vretenbrant K, Norlander B, Peterson C (2006) Measurement of paclitaxel and its metabolites in human plasma using liquid chromatography\/ion trap mass spectrometry with a sonic spray ionization interface. Rapid Commun Mass Spectrom 20:2183\u20132189. https:\/\/doi.org\/10.1002\/rcm.2567","journal-title":"Rapid Commun Mass Spectrom"},{"issue":"13","key":"3900_CR11","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1039\/c7an00367f","volume":"142","author":"N Guichard","year":"2017","unstructured":"Guichard N, Guillarme D, Bonnabry P, Fleury-Souverain S (2017) Antineoplastic drugs and their analysis: a state of the art review. Analyst 142(13):2273\u20132321. https:\/\/doi.org\/10.1039\/c7an00367f","journal-title":"Analyst"},{"key":"3900_CR12","doi-asserted-by":"publisher","first-page":"3469","DOI":"10.2147\/DDDT.S251144","volume":"14","author":"Y Harahap","year":"2020","unstructured":"Harahap Y, Ardiningsih P, Winarti AC, Purwanto DJ (2020) Analysis of the doxorubicin and doxorubicinol in the plasma of breast cancer patients for monitoring the toxicity of doxorubicin. Drug Des Devel Ther 14:3469\u20133475. https:\/\/doi.org\/10.2147\/DDDT.S251144","journal-title":"Drug Des Devel Ther"},{"issue":"14","key":"3900_CR13","doi-asserted-by":"publisher","first-page":"1111601","DOI":"10.3389\/fphar.2023.1111601","volume":"23","author":"RE Hudson","year":"2023","unstructured":"Hudson RE, Metz TD, Ward RM, McKnite AM, Enioutina EY, Sherwin CM, Watt KM, Job KM (2023) Drug exposure during pregnancy: current understanding and approaches to measure maternal-fetal drug exposure. Front Pharmacol 23(14):1111601. https:\/\/doi.org\/10.3389\/fphar.2023.1111601","journal-title":"Front Pharmacol"},{"key":"3900_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2020.113388","author":"Y Ji","year":"2020","unstructured":"Ji Y, Zhang X, Liu J, Chen Y, Meng M, Li CL, Wang L (2020) Direct quantitation of free, encapsulated, total doxorubicin and doxorubicinol in stabilized frozen human plasma to support a BE study of liposomal doxorubicin. J Pharm Biomed Anal. https:\/\/doi.org\/10.1016\/j.jpba.2020.113388","journal-title":"J Pharm Biomed Anal"},{"key":"3900_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2021.114380","volume":"206","author":"G Li","year":"2021","unstructured":"Li G, Zhao M, Zhao L (2021) Ultra-performance liquid chromatography-tandem mass spectrometry for simultaneous determination of 12 anti-tumor drugs in human plasma and its application in therapeutic drug monitoring. J Pharm Biomed Anal 206:114380. https:\/\/doi.org\/10.1016\/j.jpba.2021.114380","journal-title":"J Pharm Biomed Anal"},{"key":"3900_CR16","doi-asserted-by":"publisher","DOI":"10.1021\/AC020361S","author":"BK Matuszewski","year":"2003","unstructured":"Matuszewski BK, Constanzer ML, Chavez-Eng CM (2003) Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC\u2212MS\/MS. Anal Chem. https:\/\/doi.org\/10.1021\/AC020361S","journal-title":"Anal Chem"},{"issue":"30","key":"3900_CR17","doi-asserted-by":"publisher","first-page":"3907","DOI":"10.1016\/j.jchromb.2009.09.044","volume":"877","author":"KE Maudens","year":"2009","unstructured":"Maudens KE, Stove CP, Cocquyt VFJ, Denys H, Lambert WE (2009) Development and validation of a liquid chromatographic method for the simultaneous determination of four anthracyclines and their respective 13-S-dihydro metabolites in plasma and saliva. J Chromatogr, B: Anal Technol Biomed Life Sci 877(30):3907\u20133915. https:\/\/doi.org\/10.1016\/j.jchromb.2009.09.044","journal-title":"J Chromatogr, B: Anal Technol Biomed Life Sci"},{"key":"3900_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-80706-2","volume":"11","author":"J Nakagawa","year":"2021","unstructured":"Nakagawa J, Takahata T, Hyodo R, Chen Y, Hasui K, Sasaki K, Saito K, Ueno K, Hosoi K, Terui K, Sato A, Niioka T (2021) Evaluation for pharmacokinetic exposure of cytotoxic anticancer drugs in elderly patients receiving (R-)CHOP therapy. Sci Rep 11:1\u20138. https:\/\/doi.org\/10.1038\/s41598-020-80706-2","journal-title":"Sci Rep"},{"key":"3900_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0193500","volume":"13","author":"B Posocco","year":"2018","unstructured":"Posocco B, Buzzo M, Follegot A, Giodini L, Sorio R, Marangon E, Toffoli G (2018) A new high-performance liquid chromatography-tandem mass spectrometry method for the determination of paclitaxel and 6\u03b1-hydroxy-paclitaxel in human plasma: development, validation and application in a clinical pharmacokinetic study. PLoS ONE 13:e0193500. https:\/\/doi.org\/10.1371\/journal.pone.0193500","journal-title":"PLoS ONE"},{"issue":"3","key":"3900_CR20","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1124\/dmd.118.083766","volume":"47","author":"AD Ramirez","year":"2019","unstructured":"Ramirez AD, Collins KP, Aradi AE, Conger KA, Gustafson DL (2019) Kinetics of cyclophosphamide metabolism in humans, dogs, cats and mice and relationship to cytotoxic activity and pharmacokinetics. Drug Metab Dispos 47(3):257\u2013268. https:\/\/doi.org\/10.1124\/dmd.118.083766","journal-title":"Drug Metab Dispos"},{"key":"3900_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.placenta.2020.07.009","volume":"100","author":"JF Robinson","year":"2020","unstructured":"Robinson JF, Hamilton EG, Lam J, Chen H, Woodruff TJ (2020) Differences in cytochrome p450 enzyme expression and activity in fetal and adult tissues. Placenta 100:35\u201344. https:\/\/doi.org\/10.1016\/j.placenta.2020.07.009","journal-title":"Placenta"},{"key":"3900_CR22","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1177\/1078155219870591","volume":"26","author":"P Shu","year":"2020","unstructured":"Shu P, Zhao T, Wen B, Mendelsohn-Victor K, Sun D, Friese CR, Pai MP (2020) Application of an innovative high-throughput liquid chromatography-tandem mass spectrometry method for simultaneous analysis of 18 hazardous drugs to rule out accidental acute chemotherapy exposures in health care workers. J Oncol Pharm Pract 26:794\u2013802. https:\/\/doi.org\/10.1177\/1078155219870591","journal-title":"J Oncol Pharm Pract"},{"issue":"13","key":"3900_CR23","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.3390\/cancers14133103","volume":"14","author":"S Triarico","year":"2022","unstructured":"Triarico S, Rivetti S, Capozza MA, Romano A, Maurizi P, Mastrangelo S, Attin\u00e0 G, Ruggiero A (2022) Transplacental passage and fetal effects of antineoplastic treatment during pregnancy. Cancers (Basel) 14(13):3103. https:\/\/doi.org\/10.3390\/cancers14133103","journal-title":"Cancers (Basel)"},{"issue":"5","key":"3900_CR24","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/sj.jp.7211290","volume":"25","author":"MA Underwood","year":"2005","unstructured":"Underwood MA, Gilbert WM, Sherman MP (2005) Amniotic fluid: not just fetal urine anymore. J Perinatol 25(5):341\u2013348. https:\/\/doi.org\/10.1038\/sj.jp.7211290","journal-title":"J Perinatol"},{"key":"3900_CR25","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/bmc.544","volume":"20","author":"LD Vainchtein","year":"2006","unstructured":"Vainchtein LD, Thijssen B, Stokvis E, Rosing H, Schellens JHM, Beijnen JH (2006) A simple and sensitive assay for the quantitative analysis of paclitaxel and metabolites in human plasma using liquid chromatography\/tandem mass spectrometry. Biomed Chromatogr 20:139\u2013148. https:\/\/doi.org\/10.1002\/bmc.544","journal-title":"Biomed Chromatogr"},{"issue":"3","key":"3900_CR26","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.ygyno.2010.08.019","volume":"119","author":"K Van Calsteren","year":"2010","unstructured":"Van Calsteren K, Verbesselt R, Beijnen J, Devlieger R, De Catte L, Chai DC, Van Bree R, Heyns L, De Hoon J, Amant F (2010) Transplacental transfer of anthracyclines, vinblastine, and 4-hydroxy-cyclophosphamide in a baboon model. Gynecol Oncol 119(3):594\u2013600. https:\/\/doi.org\/10.1016\/j.ygyno.2010.08.019","journal-title":"Gynecol Oncol"},{"key":"3900_CR27","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/bmc.2826","volume":"27","author":"H Yamaguchi","year":"2013","unstructured":"Yamaguchi H, Fujikawa A, Ito H, Tanaka N, Furugen A, Miyamori K, Takahashi N, Ogura J, Kobayashi M, Yamada T, Mano N, Iseki K (2013) Quantitative determination of paclitaxel and its metabolites, 6 \u03b1 -hydroxypaclitaxel and p -3\u2032-hydroxypaclitaxel, in human plasma using column-switching liquid chromatography\/tandem mass spectrometry. Biomed Chromatogr 27:539\u2013544. https:\/\/doi.org\/10.1002\/bmc.2826","journal-title":"Biomed Chromatogr"},{"issue":"2","key":"3900_CR28","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.talanta.2006.05.003","volume":"71","author":"Y Yang","year":"2007","unstructured":"Yang Y (2007) Development and validation of a high-performance liquid chromatography-tandem mass spectrometric method for quantification of daunorubicin in rat plasma. Talanta 71(2):596\u2013604. https:\/\/doi.org\/10.1016\/j.talanta.2006.05.003","journal-title":"Talanta"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-024-03900-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-024-03900-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-024-03900-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T17:27:35Z","timestamp":1737134855000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-024-03900-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,31]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["3900"],"URL":"https:\/\/doi.org\/10.1007\/s00204-024-03900-5","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,31]]},"assertion":[{"value":"8 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol (S62388) for sampling maternal and cord blood from pregnant cancer patients receiving chemotherapy during their pregnancy was reviewed and approved by the Ethics Committee Research UZ \/ KU Leuven (EC Research).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}